Cite
Wang C, Zainal NS, Chai SJ, et al. DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor. Front Immunol. 2021;12:763086doi: 10.3389/fimmu.2021.763086.
Wang, C., Zainal, N. S., Chai, S. J., Dickie, J., Gan, C. P., Zulaziz, N., Lye, B. K. W., Sutavani, R. V., Ottensmeier, C. H., King, E. V., Abraham, M. T., Ismail, S. M. B., Lau, S. H., Kallarakkal, T. G., Mun, K. S., Zain, R. B., Abdul Rahman, Z. A., Thomas, G. J., Cheong, S. C., Savelyeva, N., & Lim, K. P. (2021). DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor. Frontiers in immunology, 12763086. https://doi.org/10.3389/fimmu.2021.763086
Wang, Chuan, et al. "DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor." Frontiers in immunology vol. 12 (2021): 763086. doi: https://doi.org/10.3389/fimmu.2021.763086
Wang C, Zainal NS, Chai SJ, Dickie J, Gan CP, Zulaziz N, Lye BKW, Sutavani RV, Ottensmeier CH, King EV, Abraham MT, Ismail SMB, Lau SH, Kallarakkal TG, Mun KS, Zain RB, Abdul Rahman ZA, Thomas GJ, Cheong SC, Savelyeva N, Lim KP. DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor. Front Immunol. 2021 Oct 18;12:763086. doi: 10.3389/fimmu.2021.763086. eCollection 2021. PMID: 34733290; PMCID: PMC8559892.
Copy
Download .nbib